Clinical trial
VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study)
NCT00056225 · National Institute on Aging (NIA), NIH · Completed
Key facts
| NCT number | NCT00056225 |
|---|---|
| Title | VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study) |
| Official title | High Dose Supplements to Reduce Homocysteine and Slow the Rate of Cognitive Decline in Alzheimer's Disease (Vitamins to Slow Alzheimer's - VITAL) |
| Lead sponsor | National Institute on Aging (NIA), NIH |
| Collaborators | Alzheimer's Disease Cooperative Study (ADCS) |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | Folate, Vitamin B6, Vitamin B12 |
| Enrollment | 340 |
| Start date | Jan 1, 2003 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Mar 10, 2003 |
| Last update posted | Jun 12, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: